Skip to main content

Month: February 2026

National Healthcare Properties Reports Fourth Quarter and Full Year 2025 Results

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on senior housing and outpatient medical facilities, today announced results for the fourth quarter and full year ended December 31, 2025. Michael Anderson, Chief Executive Officer and President, commented, “We are very pleased with the exceptional internal growth of our senior housing portfolio and the steady performance of our outpatient medical portfolio in 2025. We believe the fundamentals within the healthcare real estate industry, especially the senior housing sector, remain robust. We are excited about the year ahead and are committed to delivering strong performance across our business.” Financial Performance and Other Highlights Fourth...

Continue reading

Digital Currency X Technology Inc. Regains Compliance with Nasdaq Bid Price Requirement and Hearing Cancelled

New York, Feb. 20, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (Nasdaq: DCX) (the “Company”), a pioneering digital asset treasury management company, today announced that it received a written notification from The Nasdaq Stock Market LLC, dated February 17, 2026, confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and is therefore in full compliance with all applicable Nasdaq Capital Market listing requirements. As a result, the previously scheduled hearing before the Hearings Panel on February 24, 2026 has been canceled. The Company’s securities will continue to be listed and traded on the Nasdaq Capital Market without interruption. About Digital Currency X Technology Inc. Digital Currency X Technology Inc. (NASDAQ: DCX) is a pioneering...

Continue reading

No. 1/2026 – Financial calendar 2026/2027

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 20 February 2026ANNOUNCEMENT no. 1/2026 FINANCIAL CALENDAR 2026/2027 The financial calendar for 2026/2027 has been scheduled as follows: 2026:                            25.02.2026 Annual Report 2025                            24.03.2026  Annual General Meeting 26.08.2026 Interim Report, H1 2026 2027: 23.02.2027 Annual Report 2026 18.03.2027  Annual General MeetingCemat A/S  Frede ClausenChairman of the BoardThis announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails.AttachmentAnnouncement no. 1 – 20.02.2026 – Financial calendar

Continue reading

MARA Schedules Conference Call for Fourth Quarter and Fiscal Year 2025 Financial Results

Earnings Webcast and Conference Call Set for Thursday, February 26, 2026 at 5:00 p.m. ET Miami, FL, Feb. 20, 2026 (GLOBE NEWSWIRE) — MARA Holdings, Inc. (NASDAQ: MARA) (“MARA” or the “Company”), a leading digital energy and infrastructure company, will hold a webcast and conference call on Thursday, February 26, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the quarter and fiscal year ended December 31, 2025. Financial results will be published in a shareholder letter prior to the call on the investor relations section of the Company’s website. To register to participate in the conference call or to listen to the live audio webcast, please use this link. The webcast will also be broadcast live and available for replay via the investor relations section of the Company’s website. Earnings...

Continue reading

NEXE Innovations Ships 315,000 BPI-Certified Compostable Coffee Pods Year‑to‑Date and Introduces 8 New SKUs

WINDSOR, Ontario, Feb. 20, 2026 (GLOBE NEWSWIRE) — NEXE Innovations Inc. (“NEXE”, the “Company”, “we”, “us” or “our”) (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a compostable and innovative materials company, is pleased to announce it has shipped 315,000 BPI-certified compostable coffee pods year-to-date to two existing customers, reflecting accelerating repeat demand and SKU expansion. The orders were fulfilled for ecoBeans Coffee and a North American office coffee services (OCS) distributor, reinforcing NEXE’s growing footprint in both retail and commercial channels. The shipments included 20 SKUs, of which 8 were newly introduced products, demonstrating product line expansion and deeper customer penetration. After demonstrating commercial success through targeted...

Continue reading

FTC Solar to Announce Fourth Quarter and Full Year 2025 Financial Results Thursday, March 5, 2026

AUSTIN, Texas, Feb. 20, 2026 (GLOBE NEWSWIRE) — FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, today announced it will report its fourth quarter and full year 2025 financial results before market open on Thursday, March 5, 2026. A conference call for members of the investment community will be held at 8:30 a.m. E.T. that same day, during which the Company will discuss its fourth quarter and full year 2025 results, its outlook and other business items. This call will be webcast and can be accessed within the Investor Relations section of the FTC Solar corporate website at investor.ftcsolar.com. A replay of the conference call will also be available on the website for 30 days following the webcast. About FTC Solar, Inc.Founded in 2017 by a group of renewable energy...

Continue reading

Nasus Pharma to Participate in Upcoming Investor Conferences

TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) — Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March. Oppenheimer 36th Annual Healthcare Life Sciences ConferenceDate and time: February 25, 2026, 1:20 p.m. ET Location: Virtual (register here: https://event.summitcast.com/view/CTtthLh2Bi2D9aYoKpvtEv/KoYPJS8x3zqMuXPHfEHoSY) Format: Company presentation Speaker: Dan Teleman, Chief Executive OfficerBIO Investment & Growth SummitDate and time: March 2, 2026, 10:15 a.m. ET Location: Miami, FL Format: Company presentation Speaker: Dan Teleman, Chief Executive OfficerCitizens Life...

Continue reading

AGF Investments Announces February 2026 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) today announced the February 2026 cash distributions for AGF Enhanced U.S. Equity Income Fund*, AGF Total Return Bond Fund* and AGF Systematic Global Infrastructure ETF, which pay monthly distributions. Unitholders of record on February 27, 2026 will receive cash distributions payable on March 5, 2026. Details regarding the final “per unit” distribution amounts are as follows:ETF Ticker Exchange Cash DistributionPer Unit ($)AGF Enhanced U.S. Equity Income Fund* AENU Cboe Canada Inc. $0.181211AGF Total Return Bond Fund* ATRB Cboe Canada Inc. $0.092000AGF Systematic Global Infrastructure ETF QIF Cboe Canada Inc. $0.160670*AGF Enhanced U.S. Equity Income Fund and AGF Total Return Bond Fund are mutual funds with an ETF series option. Further...

Continue reading

NOTICE IN RESPECT OF AMENDMENTS TO THE SEVERE DISRUPTION EVENT THRESHOLD IN RESPECT OF CERTAIN CLASSES OF ETP SECURITIES

20 February 2026 LEI: 2138003QW2ZAYZODBU23 WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(the “ISSUER”)(a public company incorporated with limited liability in Ireland)  NOTICE IN RESPECT OF AMENDMENTS TO THE SEVERE DISRUPTION EVENT THRESHOLD IN RESPECT OF CERTAIN CLASSES OF ETP SECURITIES  This notice relates to the ETP Securities listed in the below (the “Affected Securities”) issued pursuant to the Issuer’s Collateralised ETP Securities Programme (the “Programme”) and its base prospectus dated 25 September 2025 (the “Base Prospectus”). Terms used in this notice but not otherwise defined shall have the same meaning ascribed to them in the Base Prospectus. BNP Paribas Financial Markets acts as Swap Provider for the Affected Securities.  The Swap Provider and the Issuer have agreed to amend the Severe Disruption Event Threshold...

Continue reading

Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal

WINNIPEG, Manitoba, Feb. 20, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE) (“Kane Biotech” or “Kane”) announces the publication of an article on its revyve® Antimicrobial wound gel in the International Wound Journal. The article “Wound Healing Property of a Novel Thermo-Reversible Wound Gel With Lasting Antimicrobial and Antibiofilm Activity” is first-authored by Dr. Jeyachchandran Visvalingam, Internal R&D Leader, and includes authors from the Miller School of Medicine, Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami. Key messages of the article as it relates to Kane’s revyve wound gel include:The thermo-reversible gel shifts from a low viscosity liquid to a form-fitting gel at body temperature, then re-liquefies when cooled for easy, atraumatic removal. revyve demonstrated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.